The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered. [electronic resource]

By: Contributor(s): Publication details: HemaSphere Jun 2018Description: e52 p. digitalISSN:
  • 2572-9241
Online resources: In: HemaSphere vol. 2
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Editorial

There are no comments on this title.

to post a comment.